MedTech Forum 2022: Bernasconi Mulls HTA Proposal, Speaks On New Device And Diagnostic Regs
Executive Summary
The Medical Device and IVD Regulations are much needed, although solutions must be found quickly to address major problems created on the way. But the HTA Regulation works against the sector, MedTech Europe’s Serge Bernasconi said in a recent interview.
You may also be interested in...
The EU HTA Regulation: How It Threatens Device Launches And Where The Solutions Lie
Medtech needs to closely monitor how the newly adopted EU HTA Regulation is rolled out and actively seek to influence its impact to avoid major obstacles ahead. MedTech Europe’s Oliver Bisazza explains why further shaping of this new text is so critical.
Sea Change In Medtech As Industry Leans To US For New Innovation
An expansive study shows the US has emerged over Europe as the preferred launch site for new medical technology because the Food and Drug Administration responds more effectively to innovation than do European regulators.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.